SCHEMBL7517324

SCHEMBL7517324

COc1cc2ncnc(Cc3ccc(C(F)(F)F)cc3)c2cc1OC

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KIT P10721 2/20 0.60
EGFR P00533 10/20 0.50
ABCG2 Q9UNQ0 1/20 0.50
KDR P35968 3/20 0.49
CSF1R P07333 2/20 0.49
PDE10A Q9Y233 2/20 0.47
MAPK7 Q13164 1/20 0.47
BRAF P15056 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HTT P42858 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
ERBB2 P04626 1/20 0.45
EPHA2 P29317 1/20 0.45
EPHB4 P54760 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7515776 0.86 EGFR (0.58) KITEGFRABCG2KDRCSF1R
SCHEMBL19792401 0.84 KDM4E (0.62) KITEGFRKDRCSF1RPDE10A
SCHEMBL7510762 0.83 EGFR (0.58) EGFRABCG2KDRPDE10AKDM4E
SCHEMBL7516992 0.83 MAPK1 (0.63) EGFRKDRCSF1RPDE10AKDM4E
SCHEMBL19797771 0.83 RET (0.56) EGFRKDRPDE10AKDM4EALDH1A1
SCHEMBL6183340 0.82 EGFR (0.61) KITEGFRKDRCSF1RKDM4E
SCHEMBL7512207 0.82 MAPK1 (0.62) EGFRABCG2CSF1RPDE10AKDM4E
SCHEMBL7510839 0.80 KIT (0.60) KITEGFRABCG2PDE10AMAPK7
SCHEMBL18158153 0.79 EGFR (0.60) KITEGFRKDRCSF1RPDE10A
SCHEMBL7516352 0.78 MAPK1 (0.51) EGFRKDRCSF1RPDE10AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832073-B1 QUINAZOLINES AND PHARMACEUTICAL COMPOSITIONS SUGEN INC (US) 2002-01-16 EP disclosed
US-6103728-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES; ANTICARCINOGENIC,-TUMOR, PROLIFERATIVE AGENTS SUGEN, INC. (US) 2000-08-15 US disclosed
EP-0832073-A1 QUINAZOLINES AND PHARMACEUTICAL COMPOSITIONS Sugen, Inc. (US) 1998-04-01 EP disclosed
WO-1996040648-A1 QUINAZOLINES AND PHARMACEUTICAL COMPOSITIONS SUGEN, INC. (US) 1996-12-19 WO disclosed